Harvey Schwartz

HSP 90 inhibitors disrupt a transient HSP 90-HSF 1 interaction and identify a noncanonical model of HSP 90-mediated HSF 1 regulation

L. Neckers, L. Sistonen, J. Trepel, 2018 .

HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation

L. Neckers, L. Sistonen, J. Trepel, 2017, bioRxiv.

Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants

L. Neckers, J. Trepel, T. Kijima, 2015, PloS one.

Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas

L. Neckers, T. Kijima, K. Beebe, 2015, Cell Stress and Chaperones.

Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas

L. Neckers, T. Kijima, K. Beebe, 2015, Cell Stress and Chaperones.

HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation

L. Neckers, L. Sistonen, J. Trepel, 2017, Scientific Reports.